HSDT Logo

Helius Medical Technologies, Inc. (HSDT) 

NASDAQ
Market Cap
$3.19M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
697 of 958
Rank in Industry
82 of 120

Largest Insider Buys in Sector

HSDT Stock Price History Chart

HSDT Stock Performance

About Helius Medical Technologies, Inc.

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The …

Insider Activity of Helius Medical Technologies, Inc.

Over the last 12 months, insiders at Helius Medical Technologies, Inc. have bought $0 and sold $0 worth of Helius Medical Technologies, Inc. stock.

On average, over the past 5 years, insiders at Helius Medical Technologies, Inc. have bought $339,212 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 5,000 shares for transaction amount of $40,475 was made by ANDREEFF DANE (President and CEO) on 2023‑12‑14.

List of Insider Buy and Sell Transactions, Helius Medical Technologies, Inc.

2023-12-14PurchasePresident and CEO
5,000
0.7564%
$8.10$40,475-81.67%
2023-12-01PurchasePresident and CEO
643
0.0932%
$6.45$4,146-72.93%
2023-11-30PurchasePresident and CEO
641
0.0922%
$6.37$4,083-72.08%
2023-08-30PurchasePresident and CEO
5,000
0.878%
$7.64$38,212-23.01%
2023-08-28PurchasePresident and CEO
5,078
0.8791%
$6.37$32,339-5.54%
2022-12-16PurchasePresident and CEO
80,041
0.2864%
$0.25$19,946-25.30%
2022-11-23PurchasePresident and CEO
85,640
0.2869%
$0.31$26,694-42.42%
2022-11-22PurchasePresident and CEO
10,300
0.0343%
$0.28$2,919-37.09%
2022-11-17PurchasePresident and CEO
106,541
0.3654%
$0.34$36,064-45.43%
2022-11-16PurchasePresident and CEO
10,000
0.0369%
$0.32$3,224-38.39%
2022-08-24PurchasePresident and CEO
23,937
0.2642%
$0.63$15,080-62.57%
2021-12-17PurchasePresident and CEO
5,100
0.1671%
$5.25$26,789-72.27%
2021-12-17PurchaseCFO and Treasurer
3,000
0.0994%
$5.31$15,929-72.27%
2021-11-12PurchasePresident and CEO
37,500
1.1813%
$8.00$300,000-75.34%
2021-09-15PurchasePresident and CEO
10,000
0.4391%
$14.72$147,222-76.75%
2021-09-10PurchasePresident and CEO
10,000
0.4316%
$14.96$149,629-76.64%
2021-09-08PurchasePresident and CEO
6,000
0.2574%
$14.83$88,957-76.46%
2021-09-07PurchasePresident and CEO
4,450
0.1935%
$14.86$66,139-75.94%
2020-05-15Purchasedirector
200,000
0.5524%
$0.56$112,000-13.31%
2020-05-14Purchasedirector
100,000
0.2631%
$0.56$56,000-17.42%

Insider Historical Profitability

<0.0001%
Deschamps PhilippePresident and CEO
3334556
89.4422%
$0.8610
Walter Blanedirector
422653
11.3367%
$0.8630
LaViscount Joyce NCFO and COO
129306
3.4684%
$0.8610
ANDREEFF DANEPresident and CEO
16512
0.4429%
$0.86270<0.0001%
STRAW EDWARD Mdirector
12500
0.3353%
$0.8610

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.